Clanet, M <br/><br/>
Interferon beta-1a in relapsing multiple sclerosis: four-year extension of the European IFNbeta-1a Dose-Comparison Study.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Apr 2004 
 - 139-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-4585 
<br/><br/><label>Standard No.: </label>10.1191/1352458504ms990oa  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adult<br/>Disability Evaluation<br/>Disease Progression<br/>Europe<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Injections, Intramuscular<br/>Interferon beta-1a<br/>Interferon-beta--administration & dosage<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Treatment Outcome